Abstract

LYCOPENE IN ASTHMA: A CLINICAL ASSESSMENT

G. Sandhyarani*, Sunil V. and M. Sarangapani

ABSTRACT

Asthma prevalance increased from 7.3% in 2001 to 8.4% in 2010. In 2010, an estimated 25.7 million people had asthma. The objective of the study is to bring out the details of Lycopene drug that downs the asthma symptoms and minimal the asthma symptoms that occur frequently by studying the safety & efficacy of Lycopene in treatment of mild to moderate asthma through open label prospective study which is a study design taking 54 Patients of either sex aged between 2 – 12 yrs with mild to moderate asthma and from the results Results showed a significant decrease in AEC, ESR and TRACK Questionnaire scores. No adverse events were reported either during or after the study.

Keywords: AEC, ESR and TRACK.